-
1
-
-
25144459980
-
The metabolic syndrome - A new worldwide definition
-
DOI 10.1016/S0140-6736(05)67402-8, PII S0140673605674028
-
Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062 (Pubitemid 41338752)
-
(2005)
Lancet
, vol.366
, Issue.9491
, pp. 1059-1062
-
-
Alberti, K.G.M.M.1
Zimmet, P.2
Shaw, J.3
-
2
-
-
0033754530
-
Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: A 6-month randomized placebo-controlled dose-response study
-
AranoffS,RosenblattS,BraithwalteSetal. Pioglitazonehydrochloridemonotherapy improvesglycemiccontrolinthetreatmentofpatientswithtype2diabetes: A6-monthrandomizedplacebo-controlleddose-responsestudy: ThePioglitazone001StudyGrouDiabetesCare2000;23:1605-1611(Pubitemid30812632)
-
(2000)
Diabetes Care
, vol.23
, Issue.11
, pp. 1605-1611
-
-
Aronoff, S.1
Rosenblatt, S.2
Braithwaite, S.3
Egan, J.W.4
Mathisen, A.L.5
Schneider, R.L.6
-
3
-
-
0022531205
-
Anorectic effect of metformin in lean and genetically obese hyperglycemic (ob/ob) mice
-
Bailey CJ, Flatt PR, Ewan C. Anorectic effect of metformin in lean and genetically obese hyperglycemic (ob/ob) mice. Arch Int Pharmacodyn Ther 1986; 282: 233-239
-
(1986)
Arch Int Pharmacodyn Ther
, Issue.282
, pp. 233-239
-
-
Bailey, C.J.1
Flatt, P.R.2
Ewan, C.3
-
4
-
-
0037258604
-
Rosiglitazone reduces urinary albumin excretion in type II diabetes
-
DOI 10.1038/sj.jhh.1001444
-
Bakris GL, Viberti G, Weston WM et al. Rosiglitazone reduces urinary albumin excretion in type 2 diabetes mellitus. J Hum Hypertens 2003; 17: 7-12 (Pubitemid 36163426)
-
(2003)
Journal of Human Hypertension
, vol.17
, Issue.1
, pp. 7-12
-
-
Bakris, G.1
Viberti, G.2
Weston, W.M.3
Heise, M.4
Porter, L.E.5
Freed, M.I.6
-
5
-
-
1442275315
-
Definitions of the insulin resistance syndrome: The 1 st World Congress on the Insulin Resistance Syndrome
-
Bioomgarden ZT. Definitions of the insulin resistance syndrome : the 1 st World Congress on the Insulin Resistance Syndrome. Diabetes Care 2004; 27: 824-830
-
(2004)
Diabetes Care
, vol.27
, pp. 824-830
-
-
Bioomgarden, Z.T.1
-
6
-
-
0029142479
-
Blood pressure lowering by pioglitazone Evidence for adirect vascular effect
-
Buchanan TA, Meehan WP, Jeng YY et al. Blood pressure lowering by pioglitazone Evidence for adirect vascular effect. J Clin Invest 1995; 96: 354-360
-
(1995)
J Clin Invest
, vol.96
, pp. 354-360
-
-
Buchanan, T.A.1
Meehan, W.P.2
Jeng, Y.Y.3
-
7
-
-
19144365586
-
A randomized controlled trial of metformin versus vitamin e or prescriptive diet in nonalcoholic fatty liver disease
-
DOI 10.1111/j.1572-0241.2005.41583.x
-
Bugianesi E, Bugiamsi E, Centilcore E et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol. 2005; 100: 1082-1090 (Pubitemid 40769045)
-
(2005)
American Journal of Gastroenterology
, vol.100
, Issue.5
, pp. 1082-1090
-
-
Bugianesi, E.1
Gentilcore, E.2
Manini, R.3
Natale, S.4
Vanni, E.5
Villanova, N.6
David, E.7
Rizzetto, M.8
Marchesini, G.9
-
8
-
-
0024385212
-
The direct effects of metformin on platelet function in vitro
-
CaterinaR,MarchettiP,BerniniWetal. Thedirecteffectsofmetforminonplateletfunctioninvitro.EurJClinPharmacol1989;37: 211-213(Pubitemid19215467)
-
(1989)
European Journal of Clinical Pharmacology
, vol.37
, Issue.2
, pp. 211-213
-
-
Caterina, R.1
Marchetti, P.2
Bernini, W.3
Giannarelli, R.4
Giannessi, D.5
Navalesi, R.6
-
9
-
-
0027193068
-
Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients
-
ChanJCN,TomlinsonB,CritchleyJAJHetal. Metabolicandhemodynamiceffectsofmetoforminand glibenclamideinnormotensiveNIDDMpatients.DiabetesCare1993;16: 1035-1038(Pubitemid23184537)
-
(1993)
Diabetes Care
, vol.16
, Issue.7
, pp. 1035-1038
-
-
Chan, J.C.N.1
Tomlinson, B.2
Critchley, J.A.J.H.3
Cockram, C.S.4
Walden, R.J.5
-
11
-
-
0026021161
-
Insulin resistance-A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
-
DeFronzo RA, Ferannini E. Insulin resistance-A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173
-
(1991)
Diabetes Care
, vol.14
, pp. 173
-
-
Defronzo, R.A.1
Ferannini, E.2
-
12
-
-
0029099086
-
The multicenter metformin study group Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus
-
DeFronzo RA, Goodman AM. The multicenter metformin study group Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995; 333: 541-549
-
(1995)
N Engl J Med
, vol.333
, pp. 541-549
-
-
Defronzo, R.A.1
Goodman, A.M.2
-
13
-
-
26244453309
-
PROactive investigators: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial in macrovascular Events); a randomized controlled trial
-
Dormandy JA, Charbonnel B, Eckland DJ étal. PROactive investigators: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macrovascular Events); a randomized controlled trial. Lancet 2005; 366:1279-1289
-
(2005)
Lancet
, vol.366
, pp. 1279-1289
-
-
Dormandy, J.A.1
Charbonnel, B.2
Eckland, D.J.3
-
14
-
-
31444436197
-
Examination Committee for Metabolic SyndromeDiagnostic Criteria: Japanese Metabolic Syndrome Diagnostic Criteria
-
Examination Committee for Metabolic SyndromeDiagnostic Criteria: Japanese Metabolic Syndrome Diagnostic Criteria. J Jpn Soc Intern Med 2005; 94: 794-809
-
(2005)
J Jpn Soc Intern Med
, vol.94
, pp. 794-809
-
-
-
15
-
-
0035897696
-
-
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesteivl in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
-
(2001)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesteivl in Adults
, vol.285
, pp. 2486-2497
-
-
-
16
-
-
0031472452
-
Efficacy of metformin in type II diabetes: Results of a double-blind, placebo-controlled, dose-response trial
-
DOI 10.1016/S0002-9343(97)00254-4, PII S0002934397002544
-
Garber AJ, Duncan TG, Goodman AM et al. Efficacy of metformin type II diabetes-results of a double-blind. Placebo-controlled, doseresponse trial. Am J Med 1997; 102: 491-497 (Pubitemid 28018651)
-
(1997)
American Journal of Medicine
, vol.103
, Issue.6
, pp. 491-497
-
-
Garber, A.J.1
Duncan, T.G.2
Goodman, A.M.3
Mills, D.J.4
Rohlf, J.L.5
-
17
-
-
0034986314
-
Comparison of effects of thiazolidinediones on cardiovascular risk factor: Observations from aclinical practice
-
Gegick CG, Altheimer MD. Comparison of effects of thiazolidinediones on cardiovascular risk factor : observations from aclinical practice. Endocr Pract2001; 7: 162-169
-
(2001)
Endocr Pract
, vol.7
, pp. 162-169
-
-
Gegick, C.G.1
Altheimer, M.D.2
-
18
-
-
0034914193
-
Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30
-
DOI 10.1053/meta.2001.24192
-
Glueck CJ, Fontaine RN, Wang P et al. Metformin reduces weight, central obesity, insulin, leptin and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism 2001 ; 50: 856-861 (Pubitemid 32700469)
-
(2001)
Metabolism: Clinical and Experimental
, vol.50
, Issue.7
, pp. 856-861
-
-
Glueck, C.J.1
Fontaine, R.N.2
Wang, P.3
Subbiah, M.T.R.4
Weber, K.5
Illig, E.6
Streicher, P.7
Sieve-Smith, L.8
Tracy, T.M.9
Lang, J.E.10
McCullough, P.11
-
19
-
-
10144224904
-
A prospective analysis of the HOMA model: The Mexico City Diabetes Study
-
Haffner SM, Kennedy E, Gonzalez C et al. A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care 1996; 19: 1138-1141
-
(1996)
Diabetes Care
, vol.19
, pp. 1138-1141
-
-
Haffner, S.M.1
Kennedy, E.2
Gonzalez, C.3
-
21
-
-
1042268736
-
Quartet Study Group, One-year glycémie control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes
-
Hanefeld M, Brunetti P, Schernthaner GH et al. Quartet Study Group, One-year glycémie control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes. Diabetes Care 2004; 27: 141-147
-
(2004)
Diabetes Care
, vol.27
, pp. 141-147
-
-
Hanefeld, M.1
Brunetti, P.2
Schernthaner, G.H.3
-
22
-
-
0032568257
-
Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
-
DOI 10.1056/NEJM199803263381303
-
Inzucchi SE, Maggs DG, Spollett GR et al. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med 1998; 338: 867-872 (Pubitemid 28135963)
-
(1998)
New England Journal of Medicine
, vol.338
, Issue.13
, pp. 867-872
-
-
Inzucchi, S.E.1
Maggs, D.G.2
Spollett, G.R.3
Page, S.L.4
Rife, F.S.5
Walton, V.6
Shulman, G.I.7
-
23
-
-
0037116638
-
Oral antihyperglycemic therapy for type 2 diabetes: Scientific review
-
InzucchiSE.Oralantihyperglycemictherapyfortype2diabetes:scientificreview. JAMA2002;287:360-372(Pubitemid34256388)
-
(2002)
Journal of the American Medical Association
, vol.287
, Issue.3
, pp. 360-372
-
-
Inzucchi, S.E.1
-
24
-
-
0024391834
-
The deadly qualtet-Upper body obesity, glucose intolerance, hyperglyceridemia, and hypertension
-
Kaplan NM. The deadly qualtet-Upper body obesity, glucose intolerance, hyperglyceridemia, and hypertension-. Arch Intern Med 1989; 149:1514
-
(1989)
Arch Intern Med
, vol.149
, pp. 1514
-
-
Kaplan, N.M.1
-
25
-
-
10444243290
-
Effects of pioglitazone on the components of diabetic dyslipidaemia: Results of double-blind, multicenter, randomised studies
-
DOI 10.1111/j.1368-5031.2004.00258.x
-
Khan M, XU Y, Edwards G et al. Effects of pioglitazone on the components of diabetic dyslipidaemia: results of double-blind, multicentre, randomised studies. Mariz Int J Clin Prat 2004; 58: 907-912 (Pubitemid 39642610)
-
(2004)
International Journal of Clinical Practice
, vol.58
, Issue.10
, pp. 907-912
-
-
Khan, M.1
Xu, Y.2
Edwards, G.3
Urquhart, R.4
Mariz, S.5
-
26
-
-
0035883890
-
Metformin in non-alcoholic steatohepatitis
-
Marchesini G, Brizi M, Blanchi G et al. Metformin in non-alcoholic steatohepatitis. Lancet 2002; 358: 893-894
-
(2002)
Lancet
, vol.358
, pp. 893-894
-
-
Marchesini, G.1
Brizi, M.2
Blanchi, G.3
-
27
-
-
0032779351
-
Molecular Mechanism of Metabolic Syndrome X: Contribution of Adipocytokines Adipocytederived Bioctive Substances
-
Matsuzawa Y, Funahashi T, Nakamura T. Molecular Mechanism of Metabolic Syndrome X : Contribution of Adipocytokines Adipocytederived Bioctive Substances. Ann NY Acad Sei 1999; 892:146
-
(1999)
Ann NY Acad Sci
, vol.892
, pp. 146
-
-
Matsuzawa, Y.1
Funahashi, T.2
Nakamura, T.3
-
28
-
-
0017737946
-
Phenformin-associated lactic acidosis: Pathogenesis and treatment
-
Misbin RI. Phenformin-associated lactic acidosis : pathogenesis and treatment. Ann Intern Med 1977; 87: 591
-
(1977)
Ann Intern Med
, vol.87
, pp. 591
-
-
Misbin, R.I.1
-
29
-
-
0030065814
-
Genetic analysis of the 1RS: Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures
-
Mitchell BD, Kammerer CM, Mahaney MC et al. Genetic analysis of the 1RS : Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vase Biol 1996; 16: 281-288
-
(1996)
Arterioscler Thromb Vase Biol
, vol.16
, pp. 281-288
-
-
Mitchell, B.D.1
Kammerer, C.M.2
Mahaney, M.C.3
-
30
-
-
0031003829
-
Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes
-
DOI 10.1016/S0895-7061(96)00406-2, PII S0895706196004062
-
Morikang E, Benson SC, Kurtz TW et al. Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myoeytes. Am J Hypertens. 1997; 10: 440-446 (Pubitemid 27195980)
-
(1997)
American Journal of Hypertension
, vol.10
, Issue.4 I
, pp. 440-446
-
-
Morikang, E.1
Benson, S.C.2
Kurtz, T.W.3
Pershadsingh, H.A.4
-
31
-
-
0027399661
-
Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects
-
A study of two ethnic groups.
-
Nagi DK, Yudkin JS. Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups. Diabetes Care 1993; 16: 621-629
-
(1993)
Diabetes Care
, vol.16
, pp. 621-629
-
-
Nagi, D.K.1
Yudkin, J.S.2
-
32
-
-
33746588255
-
Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American diabetes association and the European association for the study of diabetes
-
DOI 10.2337/dc06-9912
-
Nathan DM, Buse JB, Davidson MB et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-1972 (Pubitemid 44156663)
-
(2006)
Diabetes Care
, vol.29
, Issue.8
, pp. 1963-1972
-
-
Nathan, D.M.1
Buse, J.B.2
Davidson, M.B.3
Heine, R.J.4
Holman, R.R.5
Sherwin, R.6
Zinman, B.7
-
33
-
-
0344304678
-
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement from the American Heart Association and American Diabetes Association
-
DOI 10.1161/01.CIR.0000103683.99399.7E
-
Nesto RW, Bell D, Bonow RO et al. Thiazolidinedione use, fluid retention, and congestive heart failure : a consensus statement from the American Heart Association and American Diabetes Association. Circulation 2003; 108: 2941-2948 (Pubitemid 37517824)
-
(2003)
Circulation
, vol.108
, Issue.23
, pp. 2941-2948
-
-
Nesto, R.W.1
Bell, D.2
Bonow, R.O.3
Fonseca, V.4
Grundy, S.M.5
Horton, E.S.6
Porte, D.7
Semenkovich, C.F.8
Smith, S.9
Young, L.H.10
Kahn, R.11
-
34
-
-
0027983920
-
Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
-
DOI 10.1056/NEJM199411033311803
-
Nolan JJ, Ludvik KB, Beerdsen P et al. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994;331: 1188-1193 (Pubitemid 24331336)
-
(1994)
New England Journal of Medicine
, vol.331
, Issue.18
, pp. 1188-1193
-
-
Nolan, J.J.1
Ludvik, B.2
Beerdsen, P.3
Joyce, M.4
Olefsky, J.5
-
35
-
-
70450285558
-
Effective remedy against edema and increased weight caused by pioglitazone - Examination on 2 cases with type ii diabetes who have responded to pioglitazone
-
Otsuka A. Effective remedy against edema and increased weight caused by pioglitazone - examination on 2 cases with type ii diabetes who have responded to pioglitazone. Prog Med 2004; 24: 1809-1812
-
(2004)
Prog Med
, vol.24
, pp. 1809-1812
-
-
Otsuka, A.1
-
36
-
-
0031869676
-
Effect of metformin on food intake in obese subjects
-
DOI 10.1046/j.1365-2362.1998.00304.x
-
Paolisso G, Amato L, Eccellente R et al. Effect of metformin on food intake in obese subjects. Eur J Clin Invest 1998; 28: 441-446 (Pubitemid 28326408)
-
(1998)
European Journal of Clinical Investigation
, vol.28
, Issue.6
, pp. 441-446
-
-
Paolisso, G.1
Amato, L.2
Eccellente, R.3
Gambardella, A.4
Tagliamonte, M.R.5
Varricchio, G.6
Carella, C.7
Giugliano, D.8
D'Onofrio, F.9
-
37
-
-
14644427817
-
Impact of waist circumference on the relationship between blood pressure and insulin: The Quebec health survey
-
DOI 10.1161/01.HYP.0000155463.90018.dc
-
Poirier P, Lemieux I, Mawiège P et al. Impact of waist circumference on the relationship between blood pressure and insulin : the Quebec Health Survey. Hypertension 2005; 45: 363-367 (Pubitemid 40315804)
-
(2005)
Hypertension
, vol.45
, Issue.3
, pp. 363-367
-
-
Poirier, P.1
Lemieux, I.2
Mauriege, P.3
Dewailly, E.4
Blanchet, C.5
Bergeron, J.6
Despres, J.-P.7
-
38
-
-
1442355447
-
A Pilot Study of Pioglitazone Treatment for Nonalcoholic Steatohepatitis
-
DOI 10.1002/hep.20012
-
Promrat K, Lutchman G, Uwaifb GI et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatolpgy 2004; 39: 188-196 (Pubitemid 38461481)
-
(2004)
Hepatology
, vol.39
, Issue.1
, pp. 188-196
-
-
Promrat, K.1
Lutchman, G.2
Uwaifo, G.I.3
Freedman, R.J.4
Soza, A.5
Heller, T.6
Doo, E.7
Ghany, M.8
Premkumar, A.9
Park, Y.10
Liang, T.J.11
Yanovski, J.A.12
Kleiner, D.E.13
Hoofnagle, J.H.14
-
39
-
-
0034098771
-
Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes
-
Rasfein P, Rappaport EB, Cole ST, Yan Y et al. Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes. Diabetologia 2000; 43: 278-284
-
(2000)
Diabetologia
, vol.43
, pp. 278-284
-
-
Rasfein, P.1
Rappaport, E.B.2
Cole, S.T.3
Yan, Y.4
-
40
-
-
0024160877
-
Role of insulin resistance in human disease
-
Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595
-
(1988)
Diabetes
, vol.37
, pp. 1595
-
-
Reaven, G.M.1
-
41
-
-
70450235490
-
Affects on weight fluctuations caused by metformin hydrochloride treatment in patients with type II diabetes
-
Shimizu H, Uehara Y, Masunaga M et al. Affects on weight fluctuations caused by metformin hydrochloride treatment in patients with type II diabetes. Prog Med 2002; 22: 450-453
-
(2002)
Prog Med
, vol.22
, pp. 450-453
-
-
Shimizu, H.1
Uehara, Y.2
Masunaga, M.3
-
42
-
-
0030989050
-
2+currents and not endothelial nitric oxide production
-
2+currents and not endothelial nitric oxide production. Diabetes 1997; 46: 659-664
-
(1997)
Diabetes
, vol.46
, pp. 659-664
-
-
Song, J.1
Walsh, M.F.2
Igwe, R.3
-
43
-
-
0031977203
-
Insulin-induced vasodilation and endothelial function in obesity/insulin resistance: Effects of troglitazone
-
Tack CL, Ong MK, Lutterman JA et al. Insulin-induced vasodilation and endothelial function in obesity/insulin resistance: effects of troglitazone. Diabetologia 1998; 41: 569-576
-
(1998)
Diabetologia
, vol.41
, pp. 569-576
-
-
Tack, C.L.1
Ong, M.K.2
Lutterman, J.A.3
-
44
-
-
0032511566
-
Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34)
-
UK Prospective Diiabetes Study (UKPDS) Group
-
UK Prospective Diiabetes Study (UKPDS) Group Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34). Lancet 1998; 352: 854-865
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
-
45
-
-
0003285983
-
Definition, diagnosis and classification of diabetes mellitus and its complications
-
World Health Organization. World Health Organization, Geneva
-
World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva; 1999
-
(1999)
Part I: Diagnosis and Classification of Diabetes Mellitus.
-
-
-
46
-
-
3042541843
-
The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: A systematic review
-
DOI 10.1111/j.1365-2796.2004.01328.x
-
Wulffele MG, Kooy A, Zeeuw D de et al. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type2 diabetes mellitus : a systematic review. J Intern Med 2004; 256: 1-14 (Pubitemid 38813614)
-
(2004)
Journal of Internal Medicine
, vol.256
, Issue.1
, pp. 1-14
-
-
Wulffele, M.G.1
Kooy, A.2
De Zeeuw, D.3
Stehouwer, C.D.A.4
Gansevoort, R.T.5
-
47
-
-
0035798713
-
The mechanisms by which both heterozygous PPARa deficiency and PPARa agonist improve insulin resistance
-
Yamauchi T, Kamon J, Waki H et al. The mechanisms by which both heterozygous PPARa deficiency and PPARa agonist improve insulin resistance. J Biol Chem 2001a; 276: 41245-41254
-
(2001)
J Biol Chem
, vol.276
, pp. 41245-41254
-
-
Yamauchi, T.1
Kamon, J.2
Waki, H.3
-
48
-
-
17944365228
-
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
-
DOI 10.1038/90984
-
Yamauchi T, Kamon J, Waki H et al.The fatderived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med 2001b; 7: 941-946 (Pubitemid 32756432)
-
(2001)
Nature Medicine
, vol.7
, Issue.8
, pp. 941-946
-
-
Yamauchi, T.1
Kamon, J.2
Waki, H.3
Terauchi, Y.4
Kubota, N.5
Hara, K.6
Mori, Y.7
Ide, T.8
Murakami, K.9
Tsuboyama-Kasaoka, N.10
Ezaki, O.11
Akanuma, Y.12
Gavrilova, O.13
Vinson, C.14
Reitman, M.L.15
Kagechika, H.16
Shudo, K.17
Yoda, M.18
Nakano, Y.19
Tobe, K.20
Nagai, R.21
Kimura, S.22
Tomita, M.23
Froguel, P.24
Kadowaki, T.25
more..
-
49
-
-
1642302410
-
Effects of the peroxisomal proliferator-activated receptor-γ agonist pioglitazone on renal and hormonal responses to salt in healthy men
-
DOI 10.1210/jc.2003-031526
-
Zanchi A, Chiolero A, Maillard M et al. Effects of the peroxisomal proliferators-activated receptor-gamma agonist pioglitazoneon renal and hormonal responses to salt in healthy men. J Clin Endocrinol Metab 2004; 89: 1140-1145 (Pubitemid 38368402)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.3
, pp. 1140-1145
-
-
Zanchi, A.1
Chiolero, A.2
Maillard, M.3
Nussberger, J.4
Brunner, H.-R.5
Burnier, M.6
-
50
-
-
0028305598
-
Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity
-
Zhang HY, Ready SR, Kotchen TA. Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity. Hypertension 1994; 24: 106-110
-
(1994)
Hypertension
, vol.24
, pp. 106-110
-
-
Zhang, H.Y.1
Ready, S.R.2
Kotchen, T.A.3
-
51
-
-
0034773404
-
Role of AMP-activated protein kinase in mechanism of metformin action
-
Zhou G, Myers R, Li Y et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2004; 108: 1167-1174
-
(2004)
J Clin Invest
, vol.108
, pp. 1167-1174
-
-
Zhou, G.1
Myers, R.2
Li, Y.3
|